Wolff Financial Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$399K Hold
3,160
0.08% 80
2026
Q1
$440K Hold
3,160
0.1% 75
2025
Q4
$388K Hold
3,160
0.09% 78
2025
Q3
$351K Hold
3,160
0.08% 80
2025
Q2
$350K Hold
3,160
0.09% 78
2025
Q1
$354K Hold
3,160
0.1% 76
2024
Q4
$292K Hold
3,160
0.08% 81
2024
Q3
$265K Buy
+3,160
New +$241K 0.07% 88
2024
Q2
Sell
-3,160
Closed -$231K 54
2024
Q1
$231K Hold
3,160
0.07% 92
2023
Q4
$256K Hold
3,160
0.08% 86
2023
Q3
$237K Buy
+3,160
New +$243K 0.08% 86
2023
Q2
Sell
-3,227
Closed -$268K 54
2023
Q1
$268K Hold
3,227
0.09% 86
2022
Q4
$277K Buy
+3,227
New +$256K 0.1% 83
2022
Q1
Sell
-3,227
Closed -$234K 103
2021
Q4
$234K Buy
+3,227
New +$222K 0.09% 98
2021
Q1
$209K Buy
+3,227
New +$208K 0.1% 94
2020
Q4
Sell
-3,227
Closed -$204K 88
2020
Q3
$204K Hold
3,227
0.12% 80
2020
Q2
$248K Hold
3,227
0.16% 77
2020
Q1
$241K Hold
3,227
0.18% 73
2019
Q4
$210K Hold
3,227
0.14% 83
2019
Q3
$205K Hold
3,227
0.15% 80
2019
Q2
$218K Buy
+3,227
New +$212K 0.17% 78

Other funds holding GILD

Wolff Financial Management's GILD Position: Q2 2026 in Review

Wolff Financial Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,160 shares worth $399K. The position accounts for 0.08% of the portfolio, ranked #80.

Wolff Financial Management first reported a position in GILD in Q2 2019 and has held it in 21 quarters since. The position peaked at $440K in Q1 2026. 534 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wolff Financial Management held 3,160 shares of Gilead Sciences worth $399K as of Q2 2026.
  • Wolff Financial Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.08% of Wolff Financial Management's portfolio in Q2 2026, its #80 holding.
  • Wolff Financial Management first reported a position in Gilead Sciences in Q2 2019 and has held it in 21 quarters since.
  • Wolff Financial Management's Gilead Sciences position peaked at $440K in Q1 2026.
  • 534 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wolff Financial Management's 13F filing for Q2 2026, filed 16 Jul 2026.